Skip navigation
Pharma

PharmaPharma

18896 members | 23938 posts | Public Group

Dies ist eine aktive Gruppe für alle Experten aus der pharmzeutischen Industrie -- This is an active and large size group for pharma experts

Market Drivers & Opportunities: Technological Advancements, Increasing Incorporation of Ai Platforms in Flow Cytometry Workflows and Advancements in Flow Cytometry Software, Growing Adoption of Flow Cytometry Techniques in Research and Academia, Growing Public-Private Initiatives in the Field of Immunology and Immuno-Oncology Research, Rising Global Incidence and Prevalence of Hiv/Aids and Cancer, Increased Availability of Application-Specific Products, Growing Market Presence in Emerging Countries, Evolving Pipeline for Stem Cell Research, Adoption of Recombinant Dna Technology for Antibody Production

Global & EMEA Flow Cytometry Market: The Global & EMEA flow cytometry market valued US$ 3,676.9 Mn in 2018 and is poised to grow with a CAGR of 8.5% over 2019-2025 owing to increasing focus on innovations in the field of flow cytometry (For instance, the ZE5 Cell Analyzer from Bio-Rad, has vastly increased the complexity of fluorescent flow cytometry experiments) and launch of new products and good number of products in pipeline are the major factors driving the growth of the market

Read More @ http://bit.ly/2uER5gh

Einladung zur FAH-Informationsveranstaltung:

"Pyrrolizidinalkaloide: Aktueller regulatorischer Stand bei Phytopharmaka und deren Ausgangsstoffen, Analytik, toxikologische Untersuchungen sowie landwirtschaftliche Maßnahmen zur Pyrrolizidinalkaloidreduzierung"

Am Dienstag, dem 12. Mai 2020, in der Geschäftsstelle des BAH e. V. in Bonn

Weitere Informationen finden Sie hier: https://t1p.de/r9p0

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐬𝐚𝐦𝐩𝐥𝐞 @ https://bit.ly/2tT0BMX

𝐓𝐡𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 #𝐈𝐫𝐫𝐢𝐭𝐚𝐛𝐥𝐞𝐁𝐨𝐰𝐞𝐥𝐒𝐲𝐧𝐝𝐫𝐨𝐦𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 𝐑𝐞𝐩𝐨𝐫𝐭 𝐢𝐬 𝐚 𝐜𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐬𝐭𝐮𝐝𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐈𝐫𝐫𝐢𝐭𝐚𝐛𝐥𝐞 𝐁𝐨𝐰𝐞𝐥 𝐒𝐲𝐧𝐝𝐫𝐨𝐦𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐚𝐧𝐝 𝐢𝐭𝐬 𝐟𝐮𝐭𝐮𝐫𝐞 𝐩𝐫𝐨𝐬𝐩𝐞𝐜𝐭𝐬. 𝐓𝐡𝐞 𝐈𝐫𝐫𝐢𝐭𝐚𝐛𝐥𝐞 𝐁𝐨𝐰𝐞𝐥 𝐒𝐲𝐧𝐝𝐫𝐨𝐦𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐜𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐟𝐨𝐫 𝟐𝟔𝟒𝟎 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐔𝐒$ 𝐢𝐧 𝟐𝟎𝟏𝟖 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝟖𝟔𝟓𝟎 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐔𝐒$ 𝐛𝐲 𝐭𝐡𝐞 𝐞𝐧𝐝 𝐨𝐟 𝟐𝟎𝟐𝟓, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟔.𝟎% 𝐝𝐮𝐫𝐢𝐧𝐠 𝟐𝟎𝟏𝟗-𝟐𝟎𝟐𝟓.

𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬:- 𝐀𝐥𝐥𝐞𝐫𝐠𝐚𝐧, 𝐕𝐚𝐥𝐞𝐚𝐧𝐭 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬, 𝐓𝐚𝐤𝐞𝐝𝐚, 𝐒𝐮𝐜𝐚𝐦𝐩𝐨 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬, 𝐌𝐜𝐍𝐞𝐢𝐥 𝐂𝐨𝐧𝐬𝐮𝐦𝐞𝐫 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞, 𝐒𝐞𝐛𝐞𝐥𝐚 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬, 𝐀𝐬𝐭𝐞𝐥𝐥𝐚𝐬 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬, 𝐈𝐌 𝐇𝐞𝐚𝐥𝐭𝐡𝐒𝐜𝐢𝐞𝐧𝐜𝐞.

Group for Pharma Experts

This is a XING Group for experts from the pharmaceutical industry.